SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI
CCSI 24.99-15.9%Nov 6 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: r. c. cummings who wrote (4939)3/10/1999 5:53:00 PM
From: Cacaito  Read Replies (1) of 5736
 
The innacuracy (originated in this thread) that the
Sprx Bilicheck can not work during phototherapy is just that, false.

Fact: For both devices the phototherapy light is turn off during the
few seconds needed to do the test.

Both are base on same technology. Just call Sprx and find it out.

Respironics marketing power is going to quickly gain the customers.

The FDA approval of the Sprx Bilicheck will make royalties
that CCSI will have to negotiate with a partner more difficult.
Expect CCSI to have a single digit percentage royalty.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News